Manufacturing

Mark Witcher is senior consultant at Brevitas Consulting, witchermf@aol.com

Harry Silver is senior process/facility designer at Harry Silver Designs.

Articles

A multi-purpose biopharmaceutical manufacturing facility using a matrix of multi-functional cleanrooms can be adapted to efficiently meet the capacity challenges of both supplying clinical trials and launching products.

Multi-Purpose Biopharmaceutical Manufacturing Facilities Part 1:  Product Pipeline Manufacturing

Multi-Purpose Biopharmaceutical Manufacturing Facilities Part II:  Large-Scale Production

The SciLog SciPure FD System from Parker Bioscience is an automated single-use system for the filtration and dispensing of products into either bottles or bags.

Automated Single-Use System for Filtration and Product Dispensing

Iain MacGilp, PhD, heads manufacturing at the Glasgow facility of AMRI.

Martin Reid heads quality assurance at the Glasgow facility of AMRI.

Single-use technologies, modular systems, and robots are on the rise.

Risk-Averse Fill/Finish Industry Embraces Change

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Immobilizing the antibodies on a solid-phase support, such as a resin, and carrying out the conjugation of the payload-linker while the antibodies are bound to that support will prevent aggregation at its source.

Tackling Aggregation Challenges in ADC Production

The company is certified as a manufacturer of pressure vessels and components for use in China.

ABEC Expands Equipment Supply Capability

The new Testa Center in Uppsala, Sweden is a collaborative test bed offering biotechnology equipment from GE Healthcare for process development. 

Swedish Government and GE Healthcare Open an Innovation Center for Life Sciences

Dompé Farmaceutici’s Oxervate (cenegermin), a topical eye drop, is the first treatment approved by the agency for neurotrophic keratitis, a rare disease affecting the cornea.

FDA Approves First Drug for Rare Eye Disease

The company’s purpose-built facility in Norwich, United Kingdom specializes in plant-based expression of proteins, metabolites, and complex natural products. 

Leaf Expression Systems’ Facility Begins Operations

FDA grants support US research in continuous manufacturing monitoring and control techniques for bio/pharmaceutical manufacturing at Rutgers, MIT, and Georgia Tech.

Manufacturing, Biologic Drugs